A clinical laboratory hires a consultant to improve operations, recruit clients, advise on compliance or help launch a new service. A generic consulting agreement may not identify the precise work, who owns regulatory decisions, or how the consultant is compensated. In a laboratory serving patients whose tests are reimbursed by federal programs, those omissions can create business and fraud-and-abuse risk beyond an ordinary contract dispute. For another laboratory contract allocation issue, review control of specimens, results, and patient information.
Separate technical expertise from regulated decision authority
Define whether the consultant provides workflow recommendations, laboratory information system support, billing analysis, quality-control advice, business development or assistance with regulatory filings. The laboratory’s qualified personnel remain responsible for roles imposed by applicable CLIA and state rules. A contract should not imply that a nonqualified consultant may perform required functions solely because they have an impressive business resume.
Specify tangible deliverables: a written assessment, training materials, validated implementation plan or periodic audit report. General words like ‘strategic services’ make it difficult to assess whether the work was actually performed.
Analyze compensation and referral incentives
If the consultant introduces physicians, providers or ordering sources, review whether the payment formula might reward the volume or value of federally reimbursable business. Anti-Kickback Statute issues can exist even when the parties describe the arrangement as independent business development.
Fees should reflect legitimate services, clear methodology and relevant legal requirements. A signed agreement by itself does not establish safe-harbor compliance. If the business model changes, the compensation arrangement should be reassessed instead of continuing automatically.
Clarify data, intellectual property and confidentiality
Laboratory consultants may encounter patient information, test volumes, proprietary pricing and referral relationships. Specify permitted access, data minimization, security obligations, applicable BAAs, restrictions on using customer data and the return or deletion of information on termination.
Assign ownership of reports, software modifications, training materials and underlying intellectual property. A lab that pays for development may reasonably expect continuing access to the resulting tools; the contract should state what it receives.
Build a sensible exit and dispute process
Define milestones, review and acceptance, invoices, corrective work, termination rights, transition assistance and any conflict-of-interest disclosures. A lab that depends on a consultant for critical workflows needs a method for transferring knowledge before the relationship ends.
A contract should also address whether the consultant can work for competing organizations, but overly broad restrictive covenants should be reviewed for enforceability and practical effect.
Documentation to collect
- Statement of work and specific deliverables
- Compensation model and sample invoices
- CLIA, state licensing and supervisory role descriptions
- Access to PHI, business data and intellectual property
- Termination, milestones and conflict disclosures
Laboratory consulting works best when responsibilities and compensation match verified services. BOLO advises laboratories and healthcare businesses on contracts that reflect their regulated operations.
Reference: CMS CLIA information.
Related practice: Clinical laboratory business counsel.
For a specific question, contact BOLO Health Law or call 609-200-6677. General information only, not legal advice for an individual matter. Representation requires a conflicts check and written engagement.